Name: App Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

App Pharmaceuticals Inc.

Fresenius, Teva, Eli Lilly cancer news

Lipodox doxorubicin regulatory update

FDA importing foreign cancer drug to address Doxil shortage

Fresenius SE, Medicines Co. cardiovascular news

Fresenius SE deal

Regulatory milestones

Court denies APP motion in Angiomax suit

Solicitor General declines to appeal Angiomax decision

Debiopharm, Sun Pharmaceutical, Actavis, Hospira, Par Pharmaceutical, sanofi-aventis cancer news

Debiopharm, Fresenius, Teva, Novartis, sanofi-aventis cancer news